Formulation: A solid
Formal Name: N-((2S,3R,E)-1-(((2R,3R,4R,5S,6R)-5-(((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxyoctadec-4-en-2-yl)-12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecanamide
Purity: ≥98%
Formula Markup: C54H91N5O21
Formula Weight: 1146,3
Shelf life (days): 1460
Notes: C12 NBD globotriaosylceramide is a biologically active derivative of globotriaosylceramide that is tagged with a fluorescent C12 nitrobenzoxadiazole (C12 NBD).{39567} C12 NBD globotriaosylceramide accumulates in human umbilical vascular endothelial cells (HUVECs) treated with the α-galactosidase A inhibitor 1-deoxygalactonojirimycin (DGJ; Item No. 17179) in a concentration-dependent manner, an effect that can be reversed by overexpression of α-galactosidase A. As this product is derived from a natural source, there may be variations in the sphingoid backbone. [Matreya, LLC. Catalog No. 1631]